News

Oct
12
2020

AcouSort deltar på Investerarjakten

AcouSort kommer att delta i det livesända eventet Investerarjakten den 14 oktober. Bolagets vd Torsten Freltoft kommer att presentera...

Read More
Oct
2
2020

AcouSort initiates work on the Blue4Therapy project: The first step towards the stem cell treatment of the future

AcouSort has officially initiated the Blue4Therapy project. The aim of the project is to develop a platform for purification...

Read More
Sep
30
2020

AcouSort featured in Investerarbrevet and Stockpicker

AcouSort is featured in a new article at Swedish investor sites Stockpicker and Investerarbrevet. The article “AcouSort går från...

Read More
Oct
2
2020

AcouSort initiates work on the Blue4Therapy project: The first step towards the stem cell treatment of the future

AcouSort has officially initiated the Blue4Therapy project. The aim of the project is to develop a platform for purification...

Read More
Sep
4
2020

AcouSort participates in a new important CAMP project

AcouSort will participate in yet another CAMP project. The goal is to develop a GMP-approved production of stem cells....

Read More
Aug
26
2020

Interim report Q2 2020

On August 26, AcouSort released its interim report for the second quarter of 2020. The report can be found...

Read More
Sep
30
2020

AcouSort featured in Investerarbrevet and Stockpicker

AcouSort is featured in a new article at Swedish investor sites Stockpicker and Investerarbrevet. The article “AcouSort går från...

Read More
Apr
7
2020

Interview with CEO

“The market for consumable and semi-consumable blood-plasma separation modules is estimated to grow significantly in the coming years as...

Read More
Mar
4
2020

AcouSort’s technology can streamline health care – rapidly increasing global interest

AcouSort’s technology uses soundwaves to separate cells and other particles in biological fluids, for example blood samples. The technology...

Read More